![]() |
![]() |
![]() |
|
Vol. 8, Nos. 1-50 pp. 1-1650 Jan. 1 - Dec. 31, 2010 A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
JEVTANA
– Prostate cancer drug approval, 825
– Avandia
– – Aaron suit diversity jurisdiction (S.D. Ill.), 626
– – Douglas suit, no diversity (E.D. Mo.), 890 – Paxil product liability, no change of venue (E.D. Pa.), 11 – Trasylol product liability
– – 4 suits remanded (7th Cir.), 888
– – Mass tort, no remand (S.D. Ill.), 12 Contact the Webmaster at webmaster@bna.com Copyright © The Bureau of National Affairs, Inc. All Rights Reserved. |